| Year |
Citation |
Score |
| 2020 |
Sebastianutto I, Goyet E, Andreoli L, Font-Ingles J, Moreno-Delgado D, Bouquier N, Jahannault-Talignani C, Moutin E, Di Menna L, Maslava N, Pin JP, Fagni L, Nicoletti F, Ango F, Cenci MA, et al. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease. The Journal of Clinical Investigation. PMID 32039920 DOI: 10.1172/Jci126361 |
0.521 |
|
| 2018 |
Fieblinger T, Zanetti L, Sebastianutto I, Breger LS, Quintino L, Lockowandt M, Lundberg C, Cenci MA. Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068. PMID 29968767 DOI: 10.1038/S41598-018-28273-5 |
0.693 |
|
| 2018 |
Sebastianutto I, Cenci MA. mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia. Current Opinion in Pharmacology. 38: 81-89. PMID 29625424 DOI: 10.1016/J.Coph.2018.03.003 |
0.538 |
|
| 2017 |
Sebastianutto I, Cenci MA, Fieblinger T. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease. Neurobiology of Disease. PMID 28578004 DOI: 10.1016/J.Nbd.2017.05.011 |
0.656 |
|
| 2017 |
Alcacer C, Andreoli L, Sebastianutto I, Jakobsson J, Fieblinger T, Cenci MA. Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy. The Journal of Clinical Investigation. PMID 28112685 DOI: 10.1172/Jci90132 |
0.69 |
|
| 2016 |
Sebastianutto I, Maslava N, Hopkins CR, Cenci MA. Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists. Neurobiology of Disease. PMID 27597526 DOI: 10.1016/J.Nbd.2016.09.001 |
0.422 |
|
| 2016 |
Alcacer C, Sebastianutto I, Fieblinger T, Jakobsson J, Cenci A. Role of striatal projection neurons in the generation of L-DOPA-induced dyskinesia Parkinsonism & Related Disorders. 22: e90. DOI: 10.1016/J.Parkreldis.2015.10.189 |
0.632 |
|
| 2014 |
Fieblinger T, Sebastianutto I, Alcacer C, Bimpisidis Z, Maslava N, Sandberg S, Engblom D, Cenci MA. Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 4728-40. PMID 24672017 DOI: 10.1523/Jneurosci.2702-13.2014 |
0.671 |
|
| 2012 |
Ohlin KE, Sebastianutto I, Adkins CE, Lundblad C, Lockman PR, Cenci MA. Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease. Neuroimage. 61: 228-39. PMID 22406356 DOI: 10.1016/J.Neuroimage.2012.02.066 |
0.5 |
|
| Show low-probability matches. |